BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.140
-0.020 (-1.72%)
At close: Apr 28, 2026, 4:00 PM EDT
1.120
-0.020 (-1.75%)
After-hours: Apr 28, 2026, 7:58 PM EDT
BioCardia Employees
As of December 31, 2025, BioCardia had 21 total employees, including 17 full-time and 4 part-time employees. The number of employees increased by 1 or 5.00% compared to the previous year.
Employees
21
Change (1Y)
1
Growth (1Y)
5.00%
Revenue / Employee
n/a
Profits / Employee
-$391,810
Market Cap
12.47M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 43 |
| Moleculin Biotech | 17 |
| Reviva Pharmaceuticals Holdings | 14 |
| BioVie | 13 |
| Intensity Therapeutics | 7 |
| Traws Pharma | 7 |
| Phio Pharmaceuticals | 6 |
| Jupiter Neurosciences | 5 |
BCDA News
- 8 days ago - BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure - GlobeNewsWire
- 5 weeks ago - BioCardia Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - BioCardia Reports 2025 Business Highlights and Financial Results - GlobeNewsWire
- 5 weeks ago - BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026 - GlobeNewsWire
- 2 months ago - BioCardia Files Pre-Submission for FDA Approval of Helix™ Transendocardial Delivery Catheter for Therapeutic and Diagnostic Agent Delivery to the Heart - GlobeNewsWire
- 4 months ago - BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA - GlobeNewsWire
- 5 months ago - BioCardia to Present at December 2025 CSI Focus Devices in Heart Failure Congress - GlobeNewsWire
- 5 months ago - BioCardia Strengthens Leadership Team with The Addition of Farhan Shahab as Vice President of Quality - GlobeNewsWire